RESPONSE: Re: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4

Abstract excerpt

We are pleased to see the work of Ando et al. that addresses the functional significance of the cytochrome P450-3A4 (CYP3A4) genetic variant originally reported by our group ( 1 ). We would like to comment on the findings reported in their correspondence and contribute additional data that complement the findings of those authors. We have previously reported that the frequency of the CYP3A4 variant allele differs...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glutathione Transferases and Polymorphisms
• Share to Pharmacogenetics and Drug Metabolism
• Share to Prostate Cancer Treatment and Research